Press release
Stratophase Presents Solution for Multiplexed Detection of Biological Agents at Bio-Sensing Technology 2011
Stratophase, innovators in real-time in situ monitoring and diagnostics, will be presenting a talk entitled “Optical microchip sensors for multiplexed detection of biological agents” at this year’s Bio-Sensing conference in Amsterdam, the Netherlands, 10-12 October. The presentation by Devaki Bhatta, Stratophase’s Head of Biodetection, will outline the latest developments in bio-detection solutions utilising the company’s proprietary SpectroSens™ optical microchip technology.By using light to measure change, Stratophase’s unique technology brings precision, flexibility and cost-effectiveness to real-time monitoring and diagnostics. SpectroSens microchip bio-detector is coated with specific antibodies that bind with high specificity and affinity to biological targets. When a given toxin, bacteria or virus is present in the sample it binds and triggers a positive detection. One disposable SpectroSens microchip can be used to test multiple samples simultaneously, or several biological targets within a single sample.
To find out more, meet Stratophase at Bio-Sensing 2011 Amsterdam (10th to 12th October), or see the website at www.stratophase.com.
About Stratophase:
Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including biochemical production as well as biological detection.
The Stratophase team includes the original inventors of the SpectroSens technology as well as senior managers with a vast array of industry experience.
Alto Marketing
Office 3 Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL | UK
Media enquiries
Alto Marketing Limited
Paul Avery – Science Writer
t: +44 (0)1489 557672
e: paula@alto-marketing.com
Product enquiries
Stratophase
Sam Watts – Business Development & Commercial Officer
t: +44 (0)1794 511226
e: sam.watts@stratophase.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stratophase Presents Solution for Multiplexed Detection of Biological Agents at Bio-Sensing Technology 2011 here
News-ID: 196532 • Views: …
More Releases from Stratophase
Stratophase to Exhibit at BioTechnica 2011
SpectroSens™ Technology for Real-time Monitoring and Diagnostics to be showcased at Stand A28, Hall 9
Stratophase, innovators in real-time in situ monitoring and diagnostics, will be exhibiting and showcasing its unique SpectroSens™ optical microchip technology at Biotechnica 2011 (11th – 13th October). SpectroSens draws on Stratophase’s expertise in fibre optic communications and solid state silicon device manufacture to create a powerful sensing tool for real-time, in-line monitoring and portable biological detection.…
Optical Biodetector Successfully Detects Anthrax and Ricin Toxin in Tests
Stratophase’s technology demonstrated for label-free detection of biothreat agents as part of MoD-funded project
Stratophase, a specialist in real-time chemical and biochemical measurement, has recently announced the successful completion of the Portable Integrated Battlespace Biological Detection Technology (PIBBDT) project. The work, led by manufacturer Biral and funded by the UK Ministry of Defence, involved a consortium of commercial, academic and military specialists with expertise in collector technology, bio-detection and micro-fluidics. These…
Stratophase Successfully Completes Bio-Detection Project
Portable optical microchip technology accurately detects Foot and Mouth Disease in laboratory tests
Stratophase, a specialist in real-time chemical and biochemical measurement, has announced the successful completion of the Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project. Using Stratophase’s proprietary optical microchip technology, the goal of the proof-of-principle study was to assess the feasibility of using a self-contained, portable detection unit to accurately identify the presence of Foot…
More Releases for SpectroSens
Stratophase to Exhibit at BioTechnica 2011
SpectroSens™ Technology for Real-time Monitoring and Diagnostics to be showcased at Stand A28, Hall 9
Stratophase, innovators in real-time in situ monitoring and diagnostics, will be exhibiting and showcasing its unique SpectroSens™ optical microchip technology at Biotechnica 2011 (11th – 13th October). SpectroSens draws on Stratophase’s expertise in fibre optic communications and solid state silicon device manufacture to create a powerful sensing tool for real-time, in-line monitoring and portable biological detection.…
Optical Biodetector Successfully Detects Anthrax and Ricin Toxin in Tests
Stratophase’s technology demonstrated for label-free detection of biothreat agents as part of MoD-funded project
Stratophase, a specialist in real-time chemical and biochemical measurement, has recently announced the successful completion of the Portable Integrated Battlespace Biological Detection Technology (PIBBDT) project. The work, led by manufacturer Biral and funded by the UK Ministry of Defence, involved a consortium of commercial, academic and military specialists with expertise in collector technology, bio-detection and micro-fluidics. These…
Stratophase Successfully Completes Bio-Detection Project
Portable optical microchip technology accurately detects Foot and Mouth Disease in laboratory tests
Stratophase, a specialist in real-time chemical and biochemical measurement, has announced the successful completion of the Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project. Using Stratophase’s proprietary optical microchip technology, the goal of the proof-of-principle study was to assess the feasibility of using a self-contained, portable detection unit to accurately identify the presence of Foot…
P3SENS consortium makes headway in the development of microfluidic sample delive …
A 3.6M€ project cofunded by the 7th EU Framework Program is developing a novel biosensor platform for Point of Care Diagnosis of Cerebrovascular Disease
The P3SENS consortium has been formed to develop an immunoassay detection device suitable for use in emergency-medicine, whether diagnosis is required in an ambulance, emergency room or as part of a rapid near-patient laboratory test in a hospital environment. The requirement for such a technology to be…
